Medroxyprogesterone
- Level
- Commodity
- Parent
- 51351500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351509This classification denotes a therapeutic progestin with the molecular formula C22H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HSU1C9YRES, chemically known as 17-hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione but generally known as medroxyprogesterone, which bears US NIH Compound Identifier 10631. European Medicines Agency schedules Medroxyprogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08699MIG. World Health Organization schedules medroxyprogesterone in its Anatomical Therapeutic Chemical (ATC) Classification. MEDROXYPROGESTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medroxyprogesterone under HS 29372300 and SITC 54153. As of Q4 2014, MEDROXYPROGESTERONE remains the US FDA Preferred Term for this commodity. Medroxyprogesterone bears US NLM identifiers UMLS ID C0025147 and NCI Concept Code C629. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)C(C3)C)C)CC2)CC1)C)C(=O)C.
Same parent
Under 51351500 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.